AOI Medical, Inc. Director's dealings


 

TIDMAOI 
 
RNS Number : 2632N 
AOI Medical, Inc. 
13 February 2009 
 
Press Information 
 
                                AOI Medical, Inc. 
 
                              Directors' dealings 
 
London, UK, 13 February 2009 - AOI Medical, Inc. (the "Company" or "AOI") (AIM: 
AOI) announces that it was notified on 11 February 2009 that certain of its 
directors have dealt in shares of common stock of US$0.0001 par value of the 
Company ("Common Shares") in a number of off-market trades during the period 
from June 2008 to December 2008 which had previously not been notified to the 
Company. Details of these dealings in Common Shares are set out below. 
 
John Feltman, the Non-executive Chairman of the Company, made the following 
disposals in Common Shares during the period from June 2008 to December 2008: 
 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| Date                    | Number of Common Shares |  Price per Common Share |    Total Purchase Price | 
|                         |                         |                   (US$) |                   (US$) | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 23 June 2008            |                   1,486 |                    2.69 |                   4,000 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 1 July 2008             |                   3,000 |                    4.06 |                  12,180 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 10 July 2008            |                     900 |                    4.04 |                   3,636 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 30 July 2008            |                  13,000 |                    3.85 |                  50,050 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 25 August 2008          |                  26,000 |                    3.85 |                 100,100 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 27 August 2008          |                   4,213 |                    3.56 |                  15,000 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 31 October 2008         |                   6,807 |                    2.94 |                  20,000 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 30 November 2008        |                   7,896 |                    2.53 |                  20,000 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 24 December 2008        |                  2,000* |                 GBP1.81 |             GBP3,612.50 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 24 December 2008        |                  16,000 |                    2.52 |                  40,320 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
| 29 December 2008        |                  20,000 |                    2.52 |                  50,400 | 
+-------------------------+-------------------------+-------------------------+-------------------------+ 
* Common Shares sold to Paul Garvey, Non-executive Director of the Company 
 
In addition, on 1 November 2008 John Feltman disposed of a total of 3,000 Common 
Shares by way of gift, without receipt of any consideration. Following the above 
disposals, John Feltman's resultant shareholding is 3,575,536 Common Shares, 
equivalent to 42.38 per cent. of the Company's issued share capital. 
 
Paul Garvey, a Non-executive Director of the Company, purchased 2,000 Common 
Shares from John Feltman on 24 December 2008 for a total purchase price of 
GBP3,612.50, equivalent to a price of GBP1.81 per Common Share. Paul Garvey's 
resultant shareholding is 2,000 Common Shares, equivalent to 0.02 per cent. of 
the Company's issued share capital. 
 
    Enquiries: 
 
+-----------------------------------------------------------------+----------------------------------+ 
| AOI Medical, Inc.                                               | Tel: +1 407 770 1800             | 
+-----------------------------------------------------------------+----------------------------------+ 
| William J. Christy, CEO                                         |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
| Angela Johnston, CFO                                            |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
|                                                                 |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
| Numis Securities Limited                                        | Tel: +44 (0) 20 7260 1000        | 
+-----------------------------------------------------------------+----------------------------------+ 
| Nominated Adviser: Michael Meade / Brent Nabbs                  |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
| Corporate Broking: David Poutney                                |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
|                                                                 |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
| The Investor Relations Group                                    |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
| Erika Moran/Tom Caden                                           | Tel: +1 212 825 3210             | 
+-----------------------------------------------------------------+----------------------------------+ 
| Public Relations: Susan Morgenbesser                            |                                  | 
+-----------------------------------------------------------------+----------------------------------+ 
 
Background to AOI Medical, Inc. 
AOI is a medical device company focusing on the development and 
commercialisation of innovative orthopaedic medical devices for the spine and 
trauma markets.  It is progressing the development of three separate technology 
platforms: Ascendx(TM) VCF Reduction System, BAMF 
Trauma and Cervical Plate. Further information can be found at www.aoimedical.n 
t 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSIFFVFFIIFLIA
Aoi (Regs) (LSE:AOI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024